HIV-1 Vpu restricts Fc-mediated effector functions in vivo.

ADCC CD4 mimetics CP: Immunology Env Fc-effector functions HIV-1 Vpu broadly neutralizing antibodies humanized mice immune evasion non-neutralizing antibodies

Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
08 11 2022
Historique:
received: 01 03 2022
revised: 02 09 2022
accepted: 17 10 2022
entrez: 9 11 2022
pubmed: 10 11 2022
medline: 15 11 2022
Statut: ppublish

Résumé

Non-neutralizing antibodies (nnAbs) can eliminate HIV-1-infected cells via antibody-dependent cellular cytotoxicity (ADCC) and were identified as a correlate of protection in the RV144 vaccine trial. Fc-mediated effector functions of nnAbs were recently shown to alter the course of HIV-1 infection in vivo using a vpu-defective virus. Since Vpu is known to downregulate cell-surface CD4, which triggers conformational changes in the viral envelope glycoprotein (Env), we ask whether the lack of Vpu expression was linked to the observed nnAbs activity. We find that restoring Vpu expression greatly reduces nnAb recognition of infected cells, rendering them resistant to ADCC. Moreover, administration of nnAbs in humanized mice reduces viral loads only in animals infected with a vpu-defective but not with a wild-type virus. CD4-mimetics administration, known to "open" Env and expose nnAb epitopes, renders wild-type viruses sensitive to nnAbs Fc-effector functions. This work highlights the importance of Vpu-mediated evasion of humoral responses.

Identifiants

pubmed: 36351384
pii: S2211-1247(22)01495-4
doi: 10.1016/j.celrep.2022.111624
pmc: PMC9703018
mid: NIHMS1848911
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
HIV Antibodies 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111624

Subventions

Organisme : NIAID NIH HHS
ID : UM1 AI144462
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI148379
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI150471
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129769
Pays : United States
Organisme : NIGMS NIH HHS
ID : P01 GM056550
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131251
Pays : United States
Organisme : NIAID NIH HHS
ID : P50 AI150464
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116274
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI164562
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI150322
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI150590
Pays : United States
Organisme : NIAID NIH HHS
ID : R33 AI122384
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145164
Pays : United States

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

J Virol. 2006 Jun;80(11):5563-70
pubmed: 16699037
J Virol. 2020 Mar 17;94(7):
pubmed: 31941771
Science. 1994 Nov 11;266(5187):1024-7
pubmed: 7973652
Cell Host Microbe. 2008 Apr 17;3(4):245-52
pubmed: 18342597
Science. 2016 Mar 25;351(6280):1458-63
pubmed: 27013733
Cell. 2014 Sep 11;158(6):1243-1253
pubmed: 25215485
Nature. 2017 Aug 3;548(7665):108-111
pubmed: 28726771
Nat Struct Mol Biol. 2010 Dec;17(12):1486-91
pubmed: 21076402
J Virol. 2014 Nov;88(21):12895-906
pubmed: 25165110
J Exp Med. 2014 Nov 17;211(12):2361-72
pubmed: 25385756
Retrovirology. 2010 Dec 22;7:114
pubmed: 21176220
Sci Rep. 2016 Nov 09;6:36685
pubmed: 27827447
J Virol. 2018 May 14;92(11):
pubmed: 29514914
PLoS One. 2015 Nov 10;10(11):e0142118
pubmed: 26554585
J Virol. 2011 Oct;85(19):9708-15
pubmed: 21775449
Cell. 2015 Jun 18;161(7):1505-15
pubmed: 26091035
J Virol. 1989 Nov;63(11):4670-5
pubmed: 2677400
J Infect Dis. 2009 Apr 1;199(7):1007-18
pubmed: 19231994
Cell Host Microbe. 2018 Jan 10;23(1):110-120.e7
pubmed: 29324226
J Virol. 2017 Mar 13;91(7):
pubmed: 28100618
PLoS Pathog. 2012;8(5):e1002686
pubmed: 22693444
Nat Med. 2016 Apr;22(4):362-8
pubmed: 26998834
Nature. 2014 Nov 6;515(7525):138-42
pubmed: 25186731
AIDS Res Hum Retroviruses. 1998 Sep 20;14(14):1271-80
pubmed: 9764911
J Virol. 2008 Dec;82(24):12449-63
pubmed: 18842730
Org Process Res Dev. 2019 Nov 15;23(11):2464-2469
pubmed: 33013157
Cell. 2020 Feb 6;180(3):471-489.e22
pubmed: 32004464
Nat Struct Mol Biol. 2019 Dec;26(12):1167-1175
pubmed: 31792452
Virology. 2009 May 10;387(2):414-26
pubmed: 19298995
Nature. 2015 Jun 25;522(7557):487-91
pubmed: 25855300
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6425-30
pubmed: 24733916
mBio. 2020 May 26;11(3):
pubmed: 32457241
N Engl J Med. 2021 Mar 25;384(12):1089-1100
pubmed: 33761206
Nature. 2016 Jul 28;535(7613):556-60
pubmed: 27338952
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16538-43
pubmed: 24043801
mBio. 2019 Jun 18;10(3):
pubmed: 31213558
Science. 2010 Nov 19;330(6007):1066-71
pubmed: 20929726
Immunity. 2014 May 15;40(5):657-68
pubmed: 24768347
AIDS Res Hum Retroviruses. 2001 Dec 10;17(18):1757-65
pubmed: 11788027
J Virol. 1991 Sep;65(9):4832-8
pubmed: 1714520
J Virol. 2018 Jun 13;92(13):
pubmed: 29669829
Immunity. 2019 Jun 18;50(6):1513-1529.e9
pubmed: 31126879
J Virol. 2019 Nov 26;93(24):
pubmed: 31554684
Immunity. 2018 Aug 21;49(2):235-246.e4
pubmed: 30076100
AIDS Res Hum Retroviruses. 2017 May;33(5):428-431
pubmed: 27846736
Nature. 2012 Nov 15;491(7424):406-12
pubmed: 23151583
Cell Rep. 2015 Feb 3;10(4):586-99
pubmed: 25620704
Sci Transl Med. 2017 Jan 18;9(373):
pubmed: 28100831
Sci Rep. 2016 Nov 17;6:37225
pubmed: 27853288
Nature. 2017 Mar 23;543(7646):559-563
pubmed: 28289286
J Virol. 2016 Jun 10;90(13):6127-6139
pubmed: 27122574
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):E9659-E9667
pubmed: 30257946
PLoS Pathog. 2022 Jan 5;18(1):e1010183
pubmed: 34986207
J Immunol. 2015 Jun 15;194(12):5903-14
pubmed: 25964491
Proc Natl Acad Sci U S A. 1990 Jan;87(2):648-52
pubmed: 2300552
Cell. 2016 Jun 16;165(7):1609-1620
pubmed: 27315478
Nat Commun. 2017 Nov 23;8(1):1732
pubmed: 29170366
Cell. 2015 Jun 4;161(6):1280-92
pubmed: 26004070
Proc Natl Acad Sci U S A. 2020 Aug 4;117(31):18754-18763
pubmed: 32690707
Nature. 2013 Nov 14;503(7475):224-8
pubmed: 24172905
Front Immunol. 2019 Apr 02;10:677
pubmed: 31001276
J Virol. 1998 Apr;72(4):2855-64
pubmed: 9525605
Cell. 1997 Apr 18;89(2):263-73
pubmed: 9108481
J Virol. 2017 Mar 29;91(8):
pubmed: 28122982
Cell Host Microbe. 2019 Apr 10;25(4):578-587.e5
pubmed: 30974085
Nat Commun. 2018 Jun 18;9(1):2363
pubmed: 29915222
Proc Natl Acad Sci U S A. 1989 Mar;86(5):1624-8
pubmed: 2922401
Curr HIV Res. 2017;15(3):202-215
pubmed: 28322167
Science. 2019 Dec 6;366(6470):
pubmed: 31806786
J Virol. 2014 Nov;88(21):12669-82
pubmed: 25142607
J Virol. 2015 Jan;89(1):545-51
pubmed: 25339767
ACS Med Chem Lett. 2021 Oct 29;12(11):1824-1831
pubmed: 34795873
J Virol. 2016 Apr 29;90(10):5031-5046
pubmed: 26962221
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Cell Rep. 2022 Jan 11;38(2):110210
pubmed: 34971573
Nature. 2019 Jan;565(7739):318-323
pubmed: 30542158
Mucosal Immunol. 2014 Jan;7(1):46-56
pubmed: 23591718
Science. 2009 Oct 9;326(5950):285-9
pubmed: 19729618
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9626-E9634
pubmed: 29078283
Cell. 2018 Jun 14;173(7):1783-1795.e14
pubmed: 29731169
J Virol. 2015 Dec 30;90(6):2993-3002
pubmed: 26719277
J Virol. 1986 Aug;59(2):284-91
pubmed: 3016298
Nature. 1998 Jun 18;393(6686):648-59
pubmed: 9641677
EBioMedicine. 2016 Oct;12:208-218
pubmed: 27633463
PLoS Pathog. 2006 May;2(5):e39
pubmed: 16699598
J Virol. 2019 Jan 17;93(3):
pubmed: 30429344
Cell Host Microbe. 2016 Sep 14;20(3):381-391
pubmed: 27631701
J Exp Med. 2005 May 2;201(9):1407-19
pubmed: 15867093
Science. 2016 May 13;352(6287):828-33
pubmed: 27174988
J Virol. 1991 Aug;65(8):3973-85
pubmed: 1830110
Cell. 1988 Apr 8;53(1):55-67
pubmed: 2450679
Cell Host Microbe. 2021 Jun 9;29(6):904-916.e6
pubmed: 34019804
Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2687-94
pubmed: 25941367
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6626-33
pubmed: 23542380
J Immunol. 2016 Aug 15;197(4):1507-16
pubmed: 27385782
Science. 2016 Mar 4;351(6277):1043-8
pubmed: 26941313
Immunity. 2016 Nov 15;45(5):1108-1121
pubmed: 27851912
Curr Opin HIV AIDS. 2009 Sep;4(5):373-9
pubmed: 20048700
Science. 2016 May 20;352(6288):1001-4
pubmed: 27199430
Retrovirology. 2018 Sep 5;15(1):61
pubmed: 30185183
Proc Natl Acad Sci U S A. 2020 Jul 28;117(30):18002-18009
pubmed: 32665438
N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
N Engl J Med. 2016 Nov 24;375(21):2037-2050
pubmed: 27959728
Vaccines (Basel). 2021 Feb 27;9(3):
pubmed: 33673566
J Biol Chem. 1999 Nov 19;274(47):33800-6
pubmed: 10559275
Retrovirology. 2013 Nov 06;10:128
pubmed: 24195843
J Virol. 2014 Jun;88(11):6031-46
pubmed: 24623433
Science. 2011 Sep 16;333(6049):1633-7
pubmed: 21764753
Viruses. 2022 Apr 15;14(4):
pubmed: 35458546
J Virol. 2015 Dec 04;90(4):2127-34
pubmed: 26637462
J Virol. 2019 Oct 29;93(22):
pubmed: 31484748
Sci Transl Med. 2015 Dec 23;7(319):319ra206
pubmed: 26702094
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
EMBO Rep. 2020 Feb 5;21(2):e49351
pubmed: 31833228
Nature. 2008 Jan 24;451(7177):425-30
pubmed: 18200009
J Virol. 2012 Apr;86(8):4496-504
pubmed: 22301152
J Virol. 2012 May;86(9):5000-13
pubmed: 22357275
Nature. 1997 May 22;387(6631):426-30
pubmed: 9163431
FEBS J. 2015 Dec;282(24):4679-91
pubmed: 26411545
Nature. 2013 Nov 14;503(7475):277-80
pubmed: 24172896
Cell. 2014 Aug 28;158(5):989-999
pubmed: 25131989
AIDS Res Hum Retroviruses. 1994 Apr;10(4):359-69
pubmed: 7520721
Blood. 2011 Jan 6;117(1):145-55
pubmed: 20870901
PLoS Pathog. 2019 Feb 19;15(2):e1007572
pubmed: 30779811
Immunity. 2016 Sep 20;45(3):483-496
pubmed: 27617678
Cell Host Microbe. 2016 Apr 13;19(4):504-14
pubmed: 26996307
Nat Commun. 2021 Mar 29;12(1):1950
pubmed: 33782388
Immunity. 2019 Jan 15;50(1):241-252.e6
pubmed: 30552025
Cell Host Microbe. 2010 Nov 18;8(5):397-409
pubmed: 21075351
Proc Natl Acad Sci U S A. 2012 Nov 20;109(47):E3268-77
pubmed: 23115339
J Virol. 2022 Mar 23;96(6):e0192921
pubmed: 35080425
PLoS Pathog. 2015 Oct 30;11(10):e1005238
pubmed: 26516768
PLoS One. 2010 Jan 20;5(1):e8805
pubmed: 20098712
J Virol. 1991 Mar;65(3):1202-7
pubmed: 1847450
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11181-6
pubmed: 21690411
BMC Biol. 2020 Jul 21;18(1):91
pubmed: 32693837
Virology. 2005 Aug 15;339(1):56-69
pubmed: 15975620
Nature. 2019 Apr;568(7752):415-419
pubmed: 30971821
ACS Med Chem Lett. 2016 Jan 19;7(3):330-4
pubmed: 26985324
J Virol Methods. 2004 Feb;115(2):183-9
pubmed: 14667534
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2706-11
pubmed: 14981267
Microorganisms. 2020 May 11;8(5):
pubmed: 32403312
J Virol. 2014 Mar;88(5):2633-44
pubmed: 24352444
J Clin Invest. 2019 Jan 2;129(1):182-191
pubmed: 30475230
Nat Struct Mol Biol. 2020 Aug;27(8):726-734
pubmed: 32601441
mBio. 2016 Aug 16;7(4):
pubmed: 27531907
J Virol. 2015 Nov 18;90(3):1321-32
pubmed: 26581981
J Virol. 2017 May 12;91(11):
pubmed: 28331088
Nat Biotechnol. 2012 May 07;30(5):423-33
pubmed: 22565972
J Biol Chem. 2003 Jul 25;278(30):28346-53
pubmed: 12746459
Science. 2014 Nov 7;346(6210):759-63
pubmed: 25298114
AIDS Res Hum Retroviruses. 1996 Feb 10;12(3):191-4
pubmed: 8835195
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):E69-78
pubmed: 23237851
PLoS Pathog. 2015 Aug 03;11(8):e1005042
pubmed: 26237403
J Exp Med. 2009 Jun 8;206(6):1273-89
pubmed: 19487424
J Virol. 2012 Mar;86(5):2715-28
pubmed: 22190722
Cell. 2017 Aug 10;170(4):637-648.e10
pubmed: 28757252
Nature. 2011 Sep 22;477(7365):466-70
pubmed: 21849977
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6181-6
pubmed: 22474370
J Virol. 2015 Dec 09;90(4):2021-30
pubmed: 26656700
Cell. 2016 Sep 8;166(6):1445-1458.e12
pubmed: 27610569
Nat Med. 2017 Feb;23(2):185-191
pubmed: 28092665
Viruses. 2021 Nov 06;13(11):
pubmed: 34835042
J Exp Med. 2013 Jun 3;210(6):1235-49
pubmed: 23712429
Science. 1984 Dec 7;226(4679):1165-71
pubmed: 6095449
Nature. 2013 Apr 25;496(7446):469-76
pubmed: 23552890
Virology. 2018 Feb;515:38-45
pubmed: 29248757
Front Immunol. 2018 Nov 16;9:2613
pubmed: 30519238
Science. 1987 May 15;236(4803):819-22
pubmed: 3646751
J Virol. 2019 Aug 13;93(17):
pubmed: 31217246
Nature. 2012 Dec 6;492(7427):118-22
pubmed: 23103874
Curr Opin HIV AIDS. 2020 Sep;15(5):300-308
pubmed: 32769632
Science. 2010 Aug 13;329(5993):856-61
pubmed: 20616233
Blood. 2010 Oct 21;116(16):3004-12
pubmed: 20616215

Auteurs

Jérémie Prévost (J)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada. Electronic address: jeremie.prevost@umontreal.ca.

Sai Priya Anand (SP)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada.

Jyothi Krishnaswamy Rajashekar (JK)

Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA.

Li Zhu (L)

Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA.

Jonathan Richard (J)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada.

Guillaume Goyette (G)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.

Halima Medjahed (H)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.

Gabrielle Gendron-Lepage (G)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada.

Hung-Ching Chen (HC)

Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

Yaozong Chen (Y)

Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA.

Joshua A Horwitz (JA)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.

Michael W Grunst (MW)

Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA.

Susan Zolla-Pazner (S)

Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Barton F Haynes (BF)

Duke Human Vaccine Institute, Departments of Medicine and Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), Duke University, Durham, NC 27710, USA.

Dennis R Burton (DR)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, Harvard University, Cambridge, MA 02139, USA.

Richard A Flavell (RA)

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06519, USA.

Frank Kirchhoff (F)

Institute of Molecular Virology, Ulm University Medical Center, 89081 Ulm, Germany.

Beatrice H Hahn (BH)

Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6076, USA.

Amos B Smith (AB)

Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104-6323, USA.

Marzena Pazgier (M)

Infectious Diseases Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4712, USA.

Michel C Nussenzweig (MC)

Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.

Priti Kumar (P)

Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06510, USA.

Andrés Finzi (A)

Centre de Recherche du CHUM, Montreal, QC H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, QC H2X 0A9, Canada; Department of Microbiology and Immunology, McGill University, Montreal, QC H3A 2B4, Canada. Electronic address: andres.finzi@umontreal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH